Cure-in is developing an MRI image-guided automated breast biopsy robot system that can reduce MRI breast biopsy time from 45 minutes to 1.5 hours to 25-40 minutes.
A company staff from Cure-in said, "By developing the medical robot that help the doctors to diagnoses and treats cancer quickly and accurately, we want pave the way to become the global company that can give the medical staff confidence and trust, and patients comfort. Currently, we are under the final commercialization of the MRI image-guided automated breast biopsy robot system which we developed in the National Cancer Center as a research project in the global market."
He then said, "Our robotic system can be
used without modifying the existing MRI equipment or breast coal, so the hospitals
can keep using the equipment they have and perform the automated breast biopsy.
It has a curved biopsy needle that passes through a narrow space in the gantry.
It is equipped with an adapter device that can connect the existing breast coil
without disassembling/modifying it."
He added, "If there is a bold and
long-term investment of research fund and interest, I think Korea can lead the
field of international MRI-guided interventions."